Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Xylometazoline hydrochloride |
Is a |
False |
Xylometazoline (substance) |
Inferred relationship |
Some |
|
Xylometazoline adverse reaction |
Causative agent (attribute) |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Allergy to xylometazoline (finding) |
Causative agent (attribute) |
False |
Xylometazoline (substance) |
Inferred relationship |
Some |
|
Xylometazoline nasal solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline (substance) |
Inferred relationship |
Some |
|
Product containing xylometazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing xylometazoline in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing xylometazoline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing xylometazoline in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline (substance) |
Inferred relationship |
Some |
|
Product containing antazoline and xylometazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Allergy to xylometazoline (finding) |
Causative agent (attribute) |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Xylometazoline hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
|
Xylometazoline-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Antazoline- and xylometazoline-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
2 |
Cromoglicic acid- and xylometazoline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
2 |
Product containing only antazoline and xylometazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing only cromoglicic acid and xylometazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
2 |
Xylometazoline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
2 |
Product containing only xylometazoline in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Xylometazoline only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing only xylometazoline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely xylometazoline 500 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely xylometazoline 500 microgram/1 milliliter conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Xylometazoline (substance) |
Inferred relationship |
Some |
1 |